targeted therapy

February 14, 2018 · Greg Guthrie, ASCO staff
In this podcast, Dr. Gary Lyman describes biosimilars for cancer treatment and why they are important. He also talks about why ASCO is releasing a statement on them today. Read More >>
2017 ASCO Annual Meeting. #ASCO17
June 5, 2017 · Greg Guthrie, ASCO staff
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Today’s key research highlights include CAR T-cell therapy for multiple myeloma, immune checkpoint inhibitors for mesothelioma, and targeted therapy advances for non-small cell lung cancer and HER2-positive breast cancer. Read More >>
2017 ASCO Annual Meeting. #ASCO17
June 4, 2017 · Greg Guthrie, ASCO staff
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research released today covers how using a web-based system to report symptoms helps patients live longer, a shorter schedule of chemotherapy can be an option for certain people with colon cancer, and a targeted therapy may slow the growth of BRCA-related breast cancer. Read More >>
2017 ASCO Annual Meeting. #ASCO17
June 3, 2017 · Greg Guthrie, ASCO staff
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing. Read More >>
Oncology Briefs: Research from the ASCO Educational Book
September 15, 2016 · Himisha Beltran, MD
Identifying genetic changes has given us new insights in early detection and treatment of advanced and castration-resistant prostate cancer. Read More >>

Pages